WallStreetZenWallStreetZen

NASDAQ: ITRM
Iterum Therapeutics PLC Stock

$1.10-0.04 (-3.51%)
Updated Jun 8, 2023
ITRM Price
$1.10
Fair Value Price
$2.82
Market Cap
$14.24M
52 Week Low
$0.60
52 Week High
$7.02
P/E
-0.26x
P/B
0.75x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$50.82M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
2.07
Operating Cash Flow
-$25M
Beta
0.88
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ITRM Overview

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ITRM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ITRM ($1.10) is undervalued by 61.04% relative to our estimate of its Fair Value price of $2.82 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ITRM ($1.10) is significantly undervalued by 61.04% relative to our estimate of its Fair Value price of $2.82 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ITRM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ITRM due diligence checks available for Premium users.

Be the first to know about important ITRM news, forecast changes, insider trades & much more!

ITRM News

Valuation

ITRM fair value

Fair Value of ITRM stock based on Discounted Cash Flow (DCF)
Price
$1.10
Fair Value
$2.82
Undervalued by
61.04%
ITRM ($1.10) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ITRM ($1.10) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ITRM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ITRM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.26x
Industry
11.75x
Market
52.58x

ITRM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.75x
Industry
5.24x
ITRM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ITRM's financial health

Profit margin

Revenue
$0.0
Net Income
-$9.9M
Profit Margin
0%
ITRM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$58.1M
Liabilities
$39.2M
Debt to equity
2.07
ITRM's short-term assets ($54.25M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ITRM's short-term assets ($54.25M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ITRM's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ITRM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.6M
Investing
$5.1M
Financing
$235.0k
ITRM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ITRM vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ITRM$14.24M-3.51%-0.26x0.75x
AEZS$14.18M+2.46%-0.58x0.45x
AIMD$14.43M+2.86%-0.91x0.45x
ATHE$13.97M+0.35%-1.18x0.72x
FREQ$13.94M+3.45%-0.18x0.26x

Iterum Therapeutics Stock FAQ

What is Iterum Therapeutics's quote symbol?

(NASDAQ: ITRM) Iterum Therapeutics trades on the NASDAQ under the ticker symbol ITRM. Iterum Therapeutics stock quotes can also be displayed as NASDAQ: ITRM.

If you're new to stock investing, here's how to buy Iterum Therapeutics stock.

What is the 52 week high and low for Iterum Therapeutics (NASDAQ: ITRM)?

(NASDAQ: ITRM) Iterum Therapeutics's 52-week high was $7.02, and its 52-week low was $0.60. It is currently -84.32% from its 52-week high and 83.03% from its 52-week low.

How much is Iterum Therapeutics stock worth today?

(NASDAQ: ITRM) Iterum Therapeutics currently has 12,942,381 outstanding shares. With Iterum Therapeutics stock trading at $1.10 per share, the total value of Iterum Therapeutics stock (market capitalization) is $14.24M.

Iterum Therapeutics stock was originally listed at a price of $192.75 in May 25, 2018. If you had invested in Iterum Therapeutics stock at $192.75, your return over the last 5 years would have been -99.43%, for an annualized return of -64.41% (not including any dividends or dividend reinvestments).

How much is Iterum Therapeutics's stock price per share?

(NASDAQ: ITRM) Iterum Therapeutics stock price per share is $1.10 today (as of Jun 8, 2023).

What is Iterum Therapeutics's Market Cap?

(NASDAQ: ITRM) Iterum Therapeutics's market cap is $14.24M, as of Jun 9, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Iterum Therapeutics's market cap is calculated by multiplying ITRM's current stock price of $1.10 by ITRM's total outstanding shares of 12,942,381.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.